Klaus-Peter Radtke

Title: Klaus-Peter Radtke: Innovator in Protein Research

Introduction

Klaus-Peter Radtke is a notable inventor based in La Jolla, California. He has made significant contributions to the field of protein research, particularly in the area of protein C inhibitors and plasminogen activator inhibitors. With a total of 2 patents, Radtke's work has advanced our understanding of these critical biological components.

Latest Patents

Radtke's latest patents include a method for the functional determination of protein C inhibitor. This method involves incubating body fluids with a known amount of a plasminogen activator, fibrinogen, and a sulfated carbohydrate. The residual activity of the plasminogen activator is then determined, allowing for the quantification of protein C inhibitor. His second patent is a process for the purification of plasminogen activator inhibitor 2 (PAI-2). This process includes preincubating a PAI-2-containing solution with a compound that cleaves disulfide linkages, mixing it with a water-soluble acridine or quinoline base to precipitate impurities, and separating the precipitated impurities to obtain purified PAI-2.

Career Highlights

Klaus-Peter Radtke is associated with Behringwerke Aktiengesellschaft, where he has contributed to various research initiatives. His work has been instrumental in developing methods that enhance the understanding and application of protein inhibitors in medical science.

Collaborations

Radtke has collaborated with notable colleagues such as Norbert Heimburger and Karlheinz Wenz. These partnerships have fostered innovation and have led to advancements in their shared field of research.

Conclusion

Klaus-Peter Radtke's contributions to protein research through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the scientific community and advance our understanding of critical biological processes.